Seroquel

Release of Generic Seroquel may be Postponed

Saturday, March 17th, 2012

The manufacturers of blockbuster antipsychotic drug quetiapine (Seroquel) have asked the courts to postpone the release of the generic version of the drug to 2 December 2012 to protect the market exclusivity.
Earlier this month, the manufacturers had sued the Food and Drug Administration (FDA) in Washington for approving generic quetiapine without requiring them to carry [...]

Seroquel Recommended By European Drug Regulators As Add-On Treatment For Depression.

Monday, April 26th, 2010

The AP (4/24) reported, “AstraZeneca PLC says its schizophrenia drug Seroquel XR [quetiapine] has been recommended by” the European Medicines Agency “as an add-on treatment for depression.” The agency’s decision “overturns an earlier rejection for the drug’s new use from the Netherlands, which was acting as a reference state for the EU.” [...]

FDA says three atypical antipsychotic medications may be effective in children, but carry risks.

Monday, June 8th, 2009

The Wall Street Journal (6/5, Dooren) reported that on June 5, staff from the Food and Drug Administration (FDA) said that three medications “currently approved to treat bipolar disorder and schizophrenia in adults were effective at treating the disorders in children and adolescents, but carry significant risks.” The FDA is now “considering applications (pdf) for [...]